CHM 11.1% 2.0¢ chimeric therapeutics limited

cant stay away, page-3

  1. 296 Posts.
    CHM’s big chance to cause problems was in MMX getting funding for the infrastructure tender and submitting the RFP.

    That has happened – MMX/OPR has received funding from all the major Australian banks plus some international banks. The tender has been submitted on time – and

    Therefore CHM has failed.

    Fair enough, you could argue that the prospect of a takeover of MMX might give CHM some leverage.

    But firstly, I don’t believe MMX management or shareholders want a takeover in the near future. The full value of the company is still being proved up by drilling etc. so a takeover now would undervalue the company.

    Secondly, Sinosteel is not stupid. If they want MMX they will look at the facts/evidence, see that the CHM case is a dud, and then proceed.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(11.1%)
Mkt cap ! $17.25M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $26.18K 1.372M

Buyers (Bids)

No. Vol. Price($)
7 736556 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1462067 5
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.